FI970247A0 - Pharmaceutical compositions containing a chimeric TNF binding protein - Google Patents

Pharmaceutical compositions containing a chimeric TNF binding protein

Info

Publication number
FI970247A0
FI970247A0 FI970247A FI970247A FI970247A0 FI 970247 A0 FI970247 A0 FI 970247A0 FI 970247 A FI970247 A FI 970247A FI 970247 A FI970247 A FI 970247A FI 970247 A0 FI970247 A0 FI 970247A0
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
binding protein
compositions containing
tnf binding
chimeric tnf
Prior art date
Application number
FI970247A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI970247A (en
Inventor
Robert Fredrich Geoffrey Booth
Werner Lesslauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI970247A0 publication Critical patent/FI970247A0/en
Publication of FI970247A publication Critical patent/FI970247A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI970247A 1994-07-22 1997-01-21 Pharmaceutical compositions containing a chimeric TNF binding protein FI970247A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111455 1994-07-22
PCT/EP1995/002788 WO1996003141A1 (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a chimaeric tnf binding protein

Publications (2)

Publication Number Publication Date
FI970247A0 true FI970247A0 (en) 1997-01-21
FI970247A FI970247A (en) 1997-01-21

Family

ID=8216138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970247A FI970247A (en) 1994-07-22 1997-01-21 Pharmaceutical compositions containing a chimeric TNF binding protein

Country Status (11)

Country Link
EP (1) EP0772449A1 (en)
JP (1) JPH09508140A (en)
AU (1) AU3111995A (en)
BR (1) BR9508419A (en)
CA (1) CA2195665A1 (en)
CZ (1) CZ283219B6 (en)
FI (1) FI970247A (en)
HU (1) HUT76666A (en)
NO (1) NO970264L (en)
PL (1) PL318501A1 (en)
WO (1) WO1996003141A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
HRP970224A2 (en) * 1996-05-08 1998-04-30 Hoffmann La Roche TREATMENT OF ASTHMA WITH TNFR-Ig
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
WO1998025967A1 (en) * 1996-12-12 1998-06-18 Genentech, Inc. Hvem polypeptides and uses thereof
CA2352363A1 (en) 1998-11-27 2000-06-08 Synaptics (Uk) Limited Position sensor
KR20040052481A (en) * 2001-02-23 2004-06-23 임뮤넥스 코포레이션 Increased recovery of active proteins
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
ATE373503T1 (en) 2002-02-06 2007-10-15 Ares Trading Sa TUMOR NECROSIS FACTOR IN COMBINATION WITH INTERFERON IN DEMYELINATING DISEASES
NZ554520A (en) 2004-10-22 2010-03-26 Amgen Inc Methods for refolding of recombinant antibodies
US11111284B2 (en) 2014-08-21 2021-09-07 The General Hospital Corporation Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
EP1132471A3 (en) * 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-binding proteins
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin
AU670125B2 (en) * 1992-09-15 1996-07-04 Immunex Corporation Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
JPH08509203A (en) * 1992-10-15 1996-10-01 ダナ−ファーバー キャンサー インステテュート インコーポレイテッド Treatment of obesity-related diabetes type II insulin resistance with antagonists of TNF-α action

Also Published As

Publication number Publication date
WO1996003141A1 (en) 1996-02-08
NO970264L (en) 1997-03-24
CZ283219B6 (en) 1998-02-18
PL318501A1 (en) 1997-06-23
CA2195665A1 (en) 1996-02-08
FI970247A (en) 1997-01-21
AU3111995A (en) 1996-02-22
CZ19397A3 (en) 1997-06-11
BR9508419A (en) 1997-11-18
EP0772449A1 (en) 1997-05-14
NO970264D0 (en) 1997-01-21
JPH09508140A (en) 1997-08-19
HUT76666A (en) 1997-10-28

Similar Documents

Publication Publication Date Title
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
FI970247A0 (en) Pharmaceutical compositions containing a chimeric TNF binding protein
ZA947122B (en) Drug binding protein.
IS4565A (en) 2-methyl-thieno-benzodiazepine, oral composition
FI965202A0 (en) Pharmaceutical roofing compositions
CY2005007I1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DARIFENACINE
ID22891A (en) PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALANOL-DECONGESTANT COMBINATIONS
IS4974A (en) Pressure-spray pharmaceutical composition
HU9503199D0 (en) Pharmaceutical basic compositions
HK1027957A1 (en) Pharmaceutical composition.
DE69508180D1 (en) Hot-melt inkjet composition
GB9722600D0 (en) Pharmaceutical compositon
EP0796321A4 (en) E2 binding proteins
EE9800400A (en) Pharmaceutical compositions containing diclofenac
BR9507768A (en) Pharmaceutical composition
DE69705017D1 (en) Drug binding protein
ZA984826B (en) Novel anti-diabetic composition.
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
IT1272935B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN
LTIP2039A (en) Binding composition, containing anhydrite
IT1285093B1 (en) PHARMACEUTICAL COMPOSITION FOR CARDIOVASCULAR AND RENAL DISEASES.
SE9402924D0 (en) Novel pharmaceutical composition
GB9409736D0 (en) Biocidal protein compositions
HU9802107D0 (en) Pharmaceutical composition containing plazma proteins
KR960016881A (en) Pharmaceutical composition